Protecting Normal Cells from Radiation Damage
Author Information
Author(s): Seymour C B, Mothersill C, Mooney R, Moriarty M, Tipton K F
Primary Institution: Dublin Institute of Technology
Hypothesis
Can monoamine oxidase inhibitors protect nonmalignant human cells from ionizing radiation and chemotherapy toxicity?
Conclusion
Monoamine oxidase inhibitors l-deprenyl and clorgyline effectively protect normal human cells from radiation damage but do not provide the same protection for tumor cells.
Supporting Evidence
- l-Deprenyl significantly increased survival of normal human urothelial explants after radiation exposure.
- Clorgyline also showed radioprotective effects but to a lesser extent than l-deprenyl.
- Both drugs did not protect tumor explants from radiation damage.
Takeaway
This study found that certain drugs can help normal cells survive radiation treatment, but they don't help cancer cells in the same way.
Methodology
The study used various cell lines and explants to assess the effects of l-deprenyl and clorgyline on cell survival after exposure to gamma radiation.
Limitations
The study primarily focused on in vitro conditions, which may not fully replicate in vivo responses.
Participant Demographics
The study involved human cell lines derived from normal and tumor tissues.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website